Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
6 April to 1 May 1982
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Study undertaken to internationally accepted guidelines but before the implementation of GLP regulations.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1982
Report date:
1982

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Deviations:
yes
Remarks:
a local irritation was not created in the induction phase 24 hr before topical application
GLP compliance:
not specified
Type of study:
guinea pig maximisation test

Test material

Constituent 1
Reference substance name:
S-205
IUPAC Name:
S-205
Details on test material:
- Name of test material (as cited in study report): S-205
- Physical state: white powder

In vivo test system

Test animals

Species:
guinea pig
Strain:
Hartley
Sex:
male
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: reputable breeder
- Age at study initiation: 4 to 6 weeks old
- Weight at study initiation: 400 ± 50 g
- Housing: in suspended cages with wire mesh floors
- Diet (e.g. ad libitum): free access to Vitamin C-enriched Guinea-Pig Diet
- Water (e.g. ad libitum): free access to tap water
- Acclimation period: yes but no data on time

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21°C
- Humidity (%): 30-70%
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12 hrs dark / 12 hrs light

IN-LIFE DATES: From: 6 April To: 1 May 1982

Study design: in vivo (non-LLNA)

Induction
Route:
intradermal and epicutaneous
Vehicle:
other: Alembicol D
Challenge
Route:
epicutaneous, occlusive
Vehicle:
other: Alembicol D
No. of animals per dose:
10 guinea pigs treated with S-2055
5 guinea pigs with vehicle only
Details on study design:
RANGE FINDING TESTS:
The intradermal and topical irritancy of a range of suspensions of S-205 in Alembicol D was investigated to identify
(a) irritant test substance concentrations suitable for the induction phase of the main study and
(b) non-irritant concentrations by the topical route of administration for the challenge phase.

The following concentrations of S-205 were selected:
Induction
- Intradermal injection: 5% w/w in Alembicol D.
- Topical application: 60% w/w in Alembicol D.
Challenge
- 15% and 10% w/w in Alembicol D.

MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: 1
- Site: a 4 x 6 cm area of dorsal skin on the scapular region of the guinea-pig.
- Applications to test groups:
Intradermal injections: three pairs of intradermal injections were made simultaneously into the site
1. 0.1mL Freund's complete adjuvant 50:50 with water for injection.
2. 0.1mL S-205, 5% w/w in Alembicol D.
3. 0.1mL S-205, 5% w/w in a 50 : 50 mixture of Freund's complete adjuvant and Alembicol D.
Topical application: one week after the injection, a 2 x 4 cm patch of Whatman No. 3 paper saturated with S-205, 60% w/w in Alembicol D was placed on the same area of the skin and covered by an occlussive dressing
- Control group: treated similarly to the test animals with the exception that S-205 was omitted from the intradermal injections and topical application.
- Exposure period: 48 h

B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: 1
- Exposure period: 24 h
- Test and control groups: 2 x 2 cm Whatman No.3 papers saturated with approximately 0.2 ml of S-205, 15% w/w in Alembicol D or
S-205, 10% w/w in Alembicol D were applied to an anterior or a posterior sites, respectively, on left flank of the guinea pigs and covered by an
occlussive dressing
- Evaluation (hr after challenge): 24, 48 and 72 h after removal of the patches

SCORING SYSTEM:
Erythema and eschar formation:
0 No erythema
1 Very slight erythema (barely perceptible)
2 Well-defined erythema
3 Moderate to severe erytryema
4 Severe erythema (beet redness) to slight eschar formation (injuries in depth)

Oedema formation:
0 No oedema
1 Very slight oedema (barely perceptible) 1
2 Slight oedema (edges of area well-defined by definite raising)
3 Moderate oedema (raised approximately 1 mm)
4 Severe oedema (raised more than 1 millimeter and extending beyond the area of exposure)
Positive control substance(s):
not specified

Results and discussion

In vivo (non-LLNA)

Resultsopen allclose all
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
15% w/w in Alembicol D
No. with + reactions:
3
Total no. in group:
10
Clinical observations:
Erythemas scoring 2 (localised for 2/3 guinea pigs)
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 15% w/w in Alembicol D. No with. + reactions: 3.0. Total no. in groups: 10.0. Clinical observations: Erythemas scoring 2 (localised for 2/3 guinea pigs).
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
10% w/w in Alembicol D
No. with + reactions:
2
Total no. in group:
10
Clinical observations:
Erythemas scoring 1 and 2 (localised reaction)
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 10% w/w in Alembicol D. No with. + reactions: 2.0. Total no. in groups: 10.0. Clinical observations: Erythemas scoring 1 and 2 (localised reaction).
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
15% w/w in Alembicol D
No. with + reactions:
3
Total no. in group:
10
Clinical observations:
Erythemas scoring 1 and 2 (localised for 2/3 guinea pigs). Dryness and sloughing of the epidermis observed in animal 285 and 288
Remarks on result:
other: see Remark
Remarks:
Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 15% w/w in Alembicol D. No with. + reactions: 3.0. Total no. in groups: 10.0. Clinical observations: Erythemas scoring 1 and 2 (localised for 2/3 guinea pigs). Dryness and sloughing of the epidermis observed in animal 285 and 288.
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
10% w/w in Alembicol D
No. with + reactions:
1
Total no. in group:
10
Clinical observations:
Localised erythema scoring 1
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 10% w/w in Alembicol D. No with. + reactions: 1.0. Total no. in groups: 10.0. Clinical observations: Localised erythema scoring 1.
Reading:
other: 3rd reading
Hours after challenge:
72
Group:
test chemical
Dose level:
15% w/w in Alembicol D
No. with + reactions:
3
Total no. in group:
10
Clinical observations:
Localised erythemas scoring 1 with some dryness and sloughing of the epidermis in animal 288
Remarks on result:
other: see Remark
Remarks:
Reading: other: 3rd reading. . Hours after challenge: 72.0. Group: test group. Dose level: 15% w/w in Alembicol D. No with. + reactions: 3.0. Total no. in groups: 10.0. Clinical observations: Localised erythemas scoring 1 with some dryness and sloughing of the epidermis in animal 288.
Reading:
other: 3rd reading
Hours after challenge:
72
Group:
test chemical
Dose level:
10% w/w in Alembicol D
No. with + reactions:
0
Total no. in group:
10
Remarks on result:
other: Reading: other: 3rd reading. . Hours after challenge: 72.0. Group: test group. Dose level: 10% w/w in Alembicol D. No with. + reactions: 0.0. Total no. in groups: 10.0.

Applicant's summary and conclusion

Interpretation of results:
not sensitising
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
In this screening test, performed in ten albino guinea-pigs, S-205 produced an inconclusive result in one guinea-pig.
No evidence of delayed contact hypersensitivity was seen in the remaining nine animals.